ERBB2 and ovarian carcinoma: In addition to the increased lysosomal cathepsin activity, ErbB2-induced invasion of breast and ovarian cancer cells involves anterograde trafficking of lysosomes: in response to ErbB2 activation the lysosome distribution changes from a normal perinuclear or scattered distribution to the cell periphery13,14.